Top Markets
Coin of the day
3D Global Biotech Inc. 3D Global Biotech Inc.

3D Global Biotech Inc.

6808
Rangering i aksjer #22396
Based in New Taipei City, China, 3D Global Biotech Inc. (3DGBI) specializes in... Based in New Taipei City, China, 3D Global Biotech Inc. (3DGBI) specializes in the development of advanced medical materials designed for human body reconstruction. The company leverages sophisticated cell culture systems, cutting-edge 3D printing technology, and proprietary bio-inks hydrogel to create personalized, patient-specific cell-based medical products. Beyond product manufacturing, 3DGBI is dedicated to building platforms for human tissue and organ regeneration, engineering customized medical equipment, and undertaking significant professional research. Its extensive product range includes artificial bone substitutes, skull fixation systems, biological dressings, bio-inks, and bioprinting machinery. They also offer specialized solutions for orthopedic, dental, cranial, and scalp reconstruction. The company serves a broad spectrum of clients, including medical centers, research institutions, businesses, and distributors. 3DGBI actively fosters an interdisciplinary alliance, bringing together expertise from industry, government, academia, research, and medicine. It was established in 2014.
Aksjekurs
$1.16
Sist synkronisert: 2026-08-21
Markedsverdi
$89.35M
Endring (1 dag)
-1.22%
Endring (1 år)
-15.74%
Land
TW
Handel 3D Global Biotech Inc. (6808)

Kategori

P/B-forhold for 3D Global Biotech Inc. (6808)
P/B-forhold per 2026 TTM: 0
Ifølge 3D Global Biotech Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for 3D Global Biotech Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH